The Exchange Pulse Report published by Express Scripts predicts that compared with 2014, the year 2015 will see a greater number of younger enrollees signing up on healthcare exchanges, which could potentially drive down drug costs for specialty medications.
The Exchange Pulse Report published by Express Scripts predicts that compared with 2014, the year 2015 will see a greater number of younger enrollees signing up on healthcare exchanges, which could potentially drive down drug costs for specialty medications.
Despite this prediction on drug spending, the report found that specialty drug spending in the exchanges increased by 8% over a year: from 34% in the first quarter (Q1) of last year to 42% during Q1 of the current year. Infectious disease, particularly HIV and Hepatitis C, constituted 21% of the pharmacy spend, with HIV being 53% of the specialty claims. The hepatitis C drugs Harvoni (6.4%) and Sovaldi (3.4%) topped the charts for total pharmacy spend, and were followed by the anti-inflammatory antibody Humira (3.2%).
A particular statistic on the report needs attention: only 5% of health exchange members are responsible for 68% of total pharmacy spend, attributable to their use of high-cost medications. While medication non-adherence was higher on the exchanges compared with health plans, individuals on antidepressants fared worse with medication adherence, while hepatitis C patients did better.
The average age of the exchange enrollee has dropped by nearly 4 years, the report states, from 44.5 in Q1 of 2014, to 40.7 years in Q1 of 2015. Significantly, the number of enrollees with drug claims, and particularly specialty claims, reduced significantly between the 2 quarters being compared. The most expensive conditions treated were diabetes, HIV, and inflammatory conditions in Q1 of 2014; this year, hepatitis C replaced inflammatory conditions.
A point to note: families on exchanges, on average, earn $7260 less than families enrolled with health plans.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More